Cellect Biotechnology Ltd. APOP
Set alert
13.17 +13.17 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 12.91M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -10.80
- Beta
- 1.88
- Short ratio
- 0.07
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 19, 2021
- 50-d avg
- 17.36
- 200-d avg
- 15.47
- 1y target
- 0.00
Financial health
Altman Z-Score
5.03 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.0×
FY 2016 5y median 0.0× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.0×
FY 2016 5y median 0.0× FY 2025
P/FCF -0.0×
FY 2016 5y median -1.2× FY 2025
EV/EBITDA -38.2×
FY 2016 5y median 1.8× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -3369469.6%
FY 2016 5y median -83.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -120.5%
FY 2016 5y median 0.0% FY 2025
ROIC 0.0%
FY 2016 5y median 0.0% FY 2025
ROA -77.5%
FY 2016 5y median 0.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 0.0%
FY 2016 FY 2025
EPS (diluted) -2354.7%
FY 2016 FY 2025
Free Cash Flow -50.3%
FY 2016 FY 2025
Financial Health
Current Ratio 3.6×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 3.6×
FY 2016 5y median 0.0× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -38.2×
FY 2016 5y median -35.7× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31